Key Ingredients
Empagliflozin 5 mg: A sodium-glucose co-transporter-2 (SGLT2) inhibitor that promotes glucose excretion through urine, reduces blood glucose levels, supports weight management, and provides proven cardiovascular benefits.
Metformin 500 mg: A biguanide antidiabetic agent that lowers hepatic glucose production, improves insulin sensitivity, and enhances glucose uptake in peripheral tissues for better glycemic control.
Benefits
Dual Mechanism for Better Glycemic Control: Combines SGLT2 inhibition with insulin-sensitizing effects for superior blood sugar management.
Cardiovascular Protection: Empagliflozin reduces the risk of cardiovascular death in Type 2 diabetic patients with heart or blood vessel diseases.
Supports Weight & Blood Pressure Reduction: Helps promote mild weight loss and may support improved blood pressure.
Improves Insulin Sensitivity: Metformin enhances the body’s natural response to insulin for stable glucose levels.
Lower Risk of Hypoglycemia: Provides effective sugar control without causing low blood sugar when used alone.
Usage Instructions
Take as prescribed by a healthcare professional, typically with meals to reduce gastrointestinal discomfort. Maintain a proper diet and regular exercise for best results.
Side Effects
May include increased urination, nausea, stomach upset, mild dehydration, or genital infections. Consult a physician if symptoms persist or worsen.
General Information
- Form: Tablet
- Composition: Empagliflozin 5 mg + Metformin 500 mg
- Brand: Empagil M 5/500
- Packaging Size: 10×10
- Packaging Type: Alu-Alu
- Usage: Type 2 Diabetes Management, Cardiovascular Risk Reduction
- Country of Origin: India
Globus Labs brings you WHO-GMP–certified, high-quality Empagliflozin 5 mg + Metformin 500 mg sourced from reputed pharmaceutical manufacturers. Empagil M 5/500 is formulated to deliver safe, potent, and clinically trusted support.
